CF vs PACB · P/E 12, rev $5.94B vs rev $38.4M
CF Industries Holdings Inc (CF) versus Pacific Biosciences of California (PACB) — a side-by-side from cached financials, not a winner call.
CF Industries Holdings Inc (CF) is a agricultural inputs company listed on US.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Latest reported CF revenue for 2024-12-31 was $5.94B. Net income was $1.48B. Revenue was down 10.5% from 2023-12-31 to 2024-12-31. CF currently screens at market cap $14.98B and trailing P/E 12.2.
Latest reported PACB revenue for 2025-09-30 was $38.4M. Net income was -$38.0M. Revenue was down 3.3% from 2025-06-30 to 2025-09-30. PACB currently screens at market cap $387.1M.
CF currently screens at market cap $14.98B and trailing P/E 12.2. PACB currently screens at market cap $387.1M.
Not investment advice. Open the CF and PACB stock pages for the full models.
Not investment advice.